Leaderboards/Polyomavirus and related diseases

Polyomavirus and related diseases

Last updated June 1, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Shailender Bhatia
University of Washington
99
2
Paul Nghiem
University of Washington
90
3
Carmen Martı́nez
Josep Carreras Leukaemia Research Institute
86
4
Ash A. Alizadeh
Stanford University
75
5
Anna Karolina Matczuk
Wroclaw University of Environmental and Life Sciences
73
6
Georg A. Böhmig
Medical University of Vienna
64
7
Chengjun Wu
Dalian University
58
8
Helle C. Thiesson
University of Southern Denmark
55
9
Hans H. Hirsch
University of Basel
55
10
Maura Faraci
Istituto Giannina Gaslini
55

Rising Stars Papers

1
Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses
Journal for ImmunoTherapy of Cancer|2024
11 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Rashmi Bhakuni
University of Washington
99
2
Natalie J. Miller
University of Washington
98
3
Joshua D. Smith
Unknown
80
4
Richie Jeremian
McGill University Health Centre
53
5
Jizhang Sheng
Yantai Infectious Diseases Hospital
51
6
Fengyun Yu
Beihang University
50
7
Sébastien Briol
Cliniques Universitaires Saint-Luc
50
8
Helena Vogel
National Institutes of Health
50
9
Lachlan A Davidson
John Hunter Hospital
50
10
Simona Kraberger
Arizona State University
50

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Baohua Liu
Shenzhen University
95
2
Howard L. Kaufman
Rutgers, The State University of New Jersey
95
3
Marc Vidal
Harvard University
92
4
Davey L. Jones
Bangor University
86
5
Pawel Muranski
National Heart Lung and Blood Institute
81
6
Dirk Schadendorf
Essen University Hospital
81
7
Fabio Ciceri
Vita-Salute San Raffaele University
80
8
Mengxi Jiang
University of Alabama at Birmingham
72
9
Paul Rutgeerts
Universitair Ziekenhuis Leuven
71
10
Jaume Ordï
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
71

All-Time Leaders Papers

1
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
Journal of Clinical Oncology|2015
2.1k cit.
2
Oncolytic viruses: a new class of immunotherapy drugs
Nature Reviews Drug Discovery|2015
1.6k cit.
3
Plant and mycorrhizal regulation of rhizodeposition
New Phytologist|2004
1.3k cit.
4
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
Nature Medicine|2019
1.1k cit.
5
Identification of Potential Interaction Networks Using Sequence-Based Searches for Conserved Protein-Protein Interactions or “Interologs”
Genome Research|2001
490 cit.
6
Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: A randomized, double-blind, placebo-controlled trial
Gastroenterology|2005
419 cit.
7
Clinical landscape of oncolytic virus research in 2020
Journal for ImmunoTherapy of Cancer|2020
357 cit.
8
Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?
Nature Clinical Practice Oncology|2006
348 cit.
9
Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Before and After First Infliximab Treatment
PLoS ONE|2009
303 cit.
10
Atypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective <i>BRAF</i> Inhibition
Journal of Clinical Oncology|2012
225 cit.

Indexing Polyomavirus and related diseases Reagents

Citation data for reagents in this field is currently compiling.